person

Jolanta S. M.

Country
Austria
Department
Department of Internal Medicine III Division of Cardiology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 34 partner sites.

Specializations

Atherosclerotic Cardiovascular Disease and Lipid Management

Focused on the prevention and treatment of Atherosclerotic Cardiovascular Disease with an emphasis on elevated Lipoprotein(a) and dyslipidemia.

  • Risk stratification in high‑risk patients
  • Lp(a)‑targeted therapies
  • Management of hypercholesterolemia in chronic kidney disease

Integrates cardiovascular risk reduction with contemporary lipid‑lowering strategies.

Heart Failure and Cardiogenic Shock

Dedicated to advancing care for patients with chronic and acute Heart Failure as well as those experiencing Cardiogenic Shock.

  • Therapeutic optimization in reduced ejection fraction
  • Hemodynamic monitoring in shock states
  • Combination regimens for refractory heart failure

Emphasizes mechanistic insights and outcome‑focused interventions.

Cardiac Amyloidosis and Rare Cardiomyopathies

Specializes in the diagnosis and treatment of Transthyretin Amyloid Cardiomyopathy and other infiltrative heart diseases.

  • Novel stabilizers for transthyretin
  • Imaging biomarkers for early detection
  • Therapeutic pathways for AL amyloidosis

Targets unmet needs in rare cardiac conditions.

Acute Coronary Syndromes and Myocardial Infarction

Engages in comprehensive management of Acute Coronary Syndrome and Myocardial Infarction across the care continuum.

  • Early reperfusion strategies
  • Secondary prevention post‑MI
  • Integration of antithrombotic therapy in atrial fibrillation

Aligns acute care with long‑term cardiovascular health.

Cardiorenal Interactions and Transplant Cardiovascular Care

Investigates cardiovascular complications in renal disease, including Kidney Transplantation and related rejection phenomena.

  • Cardiovascular risk in chronic kidney disease
  • Management of antibody‑mediated rejection
  • Hemodynamic optimization in dialysis patients

Bridges cardiology and nephrology to improve outcomes in complex patient populations.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.